Is Prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?

Stroke

Volumn 46, Issue 2, 2015, Pages 369-375

  Prabhakaran, Shyam ^a   Herbers, Patricia ^b   Khoury, Jane ^b   Adeoye, Opeolu ^c   Khatri, Pooja ^c   Ferioli, Simona ^c   Kleindorfer, Dawn O ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

anticoagulants; pulmonary embolism; thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ARDEPARIN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; TINZAPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; FEMALE; GEOGRAPHIC ORIGIN; HOSPITALIZATION; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRIORITY JOURNAL; PROPHYLAXIS; UNITED STATES; CEREBRAL HEMORRHAGE; COHORT ANALYSIS; FACTUAL DATABASE; MIDDLE AGED; REGISTER; TRENDS; VENOUS THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; VENOUS THROMBOSIS;

EID: 84929132786     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008006     Document Type: Article

References (37)

1. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167-176. doi: 10.1016/S1474-4422(09)70340-0.
2. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137. doi: 10.1056/NEJMoa0707534.
3. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397. doi: 10.1016/S0140-6736(05)17826-X.
4. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355-2365. doi: 10.1056/NEJMoa1214609.
5. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129. doi: 10.1161/STR.0b013e3181ec611b.
6. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil. 2003;82:364-369. doi: 10.1097/01.PHM.0000064725.62897.A5.
7. Masotti L, Godoy DA, Napoli MD, Rabinstein AA, Paciaroni M, Ageno W. Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: what do we know about risks and benefits? Clin Appl Thromb Hemost. 2012;18:393-402. doi: 10.1177/1076029612441055.
8. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al; American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116:e391-e413. doi: 10.1161/CIRCULATIONAHA.107.183689.
9. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924-928. doi: 10.1161/STROKEAHA.107.490375.
10. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
11. Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061-2065. doi: 10.1161/01.STR.0000229878.93759.a2.
12. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005;96:1731-1733. doi: 10.1016/j. amjcard.2005.07.097.
13. André C, de Freitas GR, Fukujima MM. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles. Eur J Neurol. 2007;14:21-32. doi: 10.1111/j.1468-1331.2006.01536.x.
14. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arch Phys Med Rehabil. 1992;73(5-S):S379-S391.
15. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci. 2008;272:83-86. doi: 10.1016/j.jns.2008.04.032.
16. Wu TC, Kasam M, Harun N, Hallevi H, Bektas H, Acosta I, et al. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke. 2011;42:705-709. doi: 10.1161/STROKEAHA.110.600593.
17. Wasay M, Khan S, Zaki KS, Khealani BA, Kamal A, Azam I, et al. A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral haemorrhage. J Pak Med Assoc. 2008;58: 362-364.
18. Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study. Arch Phys Med Rehabil. 2004;85:1070-1075.
19. Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien). 2003;145:1085-1090, discussion 1090. doi: 10.1007/s00701-003-0142-y.
20. Kiphuth IC, Staykov D, Köhrmann M, Struffert T, Richter G, Bardutzky J, et al. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis. Cerebrovasc Dis. 2009;27:146-150. doi: 10.1159/000177923.
21. Tetri S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res. 2008;123:206-212. doi: 10.1016/j.thromres.2008.01.018.
22. Orken DN, Kenangil G, Ozkurt H, Guner C, Gundogdu L, Basak M, et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist. 2009;15:329-331. doi: 10.1097/NRL.0b013e3181a93bac.
23. Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr. 1988;66:1182-1183.
24. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54:466-467.
25. Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost. 2011;9:893-898. doi: 10.1111/j.1538-7836.2011.04241.x.
26. Geeganage CM, Sprigg N, Bath MW, Bath PM. Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis. 2013;22:1018-1027. doi: 10.1016/j. jstrokecerebrovasdis.2012.03.005.
27. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res. 2007;119:265-274. doi: 10.1016/j.thromres.2006.03.010
28. Lederle FA, Zylla D, MacDonald R, Wilt TJ. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2011;155:602-615. doi: 10.7326/0003-4819-155-9-201111010-00008.
29. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. doi: 10.1161/STR.0b013e318284056a.
30. Shinohara Y, Yanagihara T, Abe K, Yoshimine T, Fujinaka T, Chuma T, et al. III. Intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2011;20(suppl 4):S74-S99. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.005.
31. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, et al. Recommendations for the management of intracranial haemorrhage - part I: Spontaneous intracerebral haemorrhage. The European Stroke Initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis. 2006;22:294-316.
32. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al; American College of Chest Physicians. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e195S-e226S. doi: 10.1378/chest.11-2296.
33. National Stroke Foundation. Clinical guidelines for stroke management 2010. http://strokefoundation.com.au/health-professionals/tools-andresources/clinical-guidelines-for-stroke-prevention-and-management/. Accessed November 3, 2014.
34. National Institute for Health and Care Excellence (NICE). Reducing the risk of VTE (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. http://guidance.nice.org.uk/CG92. Accessed November 3, 2014.
35. The Joint Commission disease specific care certification program. http://www.jointcommission.org/assets/1/18/stroke-pm-implementation-guide-ver-2a.pdf. Accessed November 3, 2014.
36. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005;43:480-485.
37. Leone MA, Capponi A, Varrasi C, Tarletti R, Monaco F. Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database. Neurol Sci. 2004;25:281-288. doi: 10.1007/s10072-004-0355-8.